Our partners
Innovation in the heart of Paris.
The purpose of the MEARY Center is to catalyze the contribution of innovation in cell and gene therapies in order to promote and accelerate access to innovation in the healthcare system, to develop the national capacity to fulfill its mission of providing the best possible care to all patients, at a lower cost and with an industrial level of quality and safety.
This raison d'être is obviously developed with regard to the issues and challenges specific to the field of biotherapies, in particular the need to reduce costs and increase production capacity.
The MEARY Center is proud of these fruitful collaborations:
SMARTIMMUNE
Smart Immune, a clinical stage biotechnology company, is developing an allogeneic cell therapy platform called ProTcell. This platform exploits the physiology of the thymus to rearm the immune system in record time.
MILTENYI BIOTEC
For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.
MADECELL
MadeCELL offers integrated management software, a unique solution, in response to the specific needs of major players in the field of cell, gene and tissue therapy.
EVERZOM
EVerZom is an exosome company developing a large-scale GMP-compliant manufacturing platform for exosome-based therapies based on a patented method.